(-)-epigallocatechin 3-gallate decreases expression ISO RGD:732381 6480464 epigallocatechin gallate results in decreased expression of CPE mRNA CTD PMID:16084531 (S)-10-[(DIMETHYLAMINO)METHYL]-4-ETHYL-4,9-DIHYDROXY-1H-PYRANO[3',4':6,7]INOLIZINO[1,2-B]-QUINOLINE-3,14(4H,12H)-DIONE increases expression EXP 6480464 Topotecan results in increased expression of CPE mRNA CTD PMID:25729387 (S)-10-[(DIMETHYLAMINO)METHYL]-4-ETHYL-4,9-DIHYDROXY-1H-PYRANO[3',4':6,7]INOLIZINO[1,2-B]-QUINOLINE-3,14(4H,12H)-DIONE multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of CPE mRNA CTD PMID:25729387 17alpha-ethynylestradiol affects expression ISO RGD:732382 6480464 Ethinyl Estradiol affects the expression of CPE mRNA CTD PMID:17555576 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of CPE mRNA CTD PMID:12075121 more ... 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of CPE mRNA CTD PMID:16079270 , PMID:17351261 17alpha-ethynylestradiol multiple interactions ISO RGD:732382 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of CPE mRNA CTD PMID:17942748 17alpha-ethynylestradiol decreases expression ISO RGD:732382 6480464 Ethinyl Estradiol results in decreased expression of CPE mRNA CTD PMID:16174780 , PMID:17942748 17beta-estradiol increases expression ISO RGD:732381 6480464 Estradiol results in increased expression of CPE mRNA CTD PMID:19619570 17beta-estradiol multiple interactions ISO RGD:732381 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of CPE mRNA CTD PMID:19619570 17beta-estradiol affects expression ISO RGD:732381 6480464 Estradiol affects the expression of CPE mRNA CTD PMID:14699072 2,2',5,5'-tetrachlorobiphenyl decreases expression EXP 6480464 2 more ... CTD PMID:23829299 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:732381 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of CPE mRNA CTD PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:732382 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of CPE mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:732381 6480464 Tetrachlorodibenzodioxin results in decreased expression of CPE mRNA CTD PMID:19619570 3,7-dihydropurine-6-thione increases expression EXP 6480464 Mercaptopurine results in increased expression of CPE mRNA CTD PMID:23358152 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:732381 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of CPE mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol multiple interactions ISO RGD:732381 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of CPE mRNA CTD PMID:28628672 4-hydroxynon-2-enal decreases expression ISO RGD:732381 6480464 4-hydroxy-2-nonenal results in decreased expression of CPE mRNA CTD PMID:12419474 4-hydroxyphenyl retinamide increases expression ISO RGD:732382 6480464 Fenretinide results in increased expression of CPE mRNA CTD PMID:28973697 5-azacytidine increases expression ISO RGD:732381 6480464 Azacitidine results in increased expression of CPE mRNA CTD PMID:20823114 5-fluorouracil affects response to substance ISO RGD:732381 6480464 CPE protein affects the susceptibility to Fluorouracil CTD PMID:15352031 5-fluorouracil increases expression ISO RGD:732381 6480464 Fluorouracil results in increased expression of CPE protein CTD PMID:15352031 aflatoxin B1 increases methylation ISO RGD:732381 6480464 Aflatoxin B1 results in increased methylation of CPE gene CTD PMID:27153756 alendronic acid affects expression EXP 6480464 Alendronate affects the expression of CPE mRNA CTD PMID:16079270 all-trans-retinoic acid increases expression ISO RGD:732381 6480464 Tretinoin results in increased expression of CPE mRNA CTD PMID:21934132 all-trans-retinoic acid increases expression ISO RGD:732382 6480464 Tretinoin results in increased expression of CPE mRNA CTD PMID:16604517 benzo[a]pyrene decreases expression ISO RGD:732382 6480464 Benzo(a)pyrene results in decreased expression of CPE mRNA CTD PMID:19770486 , PMID:22610609 benzo[a]pyrene diol epoxide I increases expression ISO RGD:732381 6480464 7 more ... CTD PMID:20382639 beta-naphthoflavone multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CPE mRNA CTD PMID:18164116 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of CPE mRNA CTD PMID:12075121 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of CPE mRNA CTD PMID:25181051 bisphenol A increases expression ISO RGD:732382 6480464 bisphenol A results in increased expression of CPE mRNA CTD PMID:26063408 cadmium atom increases expression ISO RGD:732382 6480464 Cadmium results in increased expression of CPE mRNA CTD PMID:24067728 cadmium dichloride decreases methylation EXP 6480464 Cadmium Chloride results in decreased methylation of CPE promoter CTD PMID:22457795 carbon nanotube decreases expression ISO RGD:732382 6480464 Nanotubes, Carbon analog results in decreased expression of CPE mRNA, Nanotubes, Carbon results in decreased expression of CPE mRNA CTD PMID:25554681 , PMID:25620056 casticin increases expression ISO RGD:732382 6480464 casticin results in increased expression of CPE mRNA CTD PMID:28444820 chromium atom decreases expression ISO RGD:732381 6480464 Chromium results in decreased expression of CPE mRNA CTD PMID:21437242 chromium(3+) decreases expression ISO RGD:732381 6480464 Chromium results in decreased expression of CPE mRNA CTD PMID:21437242 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of CPE mRNA CTD PMID:22023808 cisplatin increases expression ISO RGD:732381 6480464 Cisplatin results in increased expression of CPE mRNA CTD PMID:27392435 cisplatin multiple interactions ISO RGD:732381 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of CPE mRNA CTD PMID:27392435 clobetasol increases expression ISO RGD:732382 6480464 Clobetasol results in increased expression of CPE mRNA CTD PMID:27462272 copper atom multiple interactions ISO RGD:732382 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of CPE mRNA CTD PMID:15467011 copper atom increases expression EXP 6480464 Copper results in increased expression of CPE mRNA CTD PMID:30556269 copper(0) multiple interactions ISO RGD:732382 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of CPE mRNA CTD PMID:15467011 copper(0) increases expression EXP 6480464 Copper results in increased expression of CPE mRNA CTD PMID:30556269 copper(2+) multiple interactions ISO RGD:732382 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of CPE mRNA CTD PMID:15467011 copper(2+) increases expression EXP 6480464 Copper results in increased expression of CPE mRNA CTD PMID:30556269 copper(II) sulfate decreases expression ISO RGD:732381 6480464 Copper Sulfate results in decreased expression of CPE mRNA CTD PMID:19549813 coumestrol decreases expression ISO RGD:732381 6480464 Coumestrol results in decreased expression of CPE mRNA CTD PMID:19167446 cyclosporin A decreases expression ISO RGD:732381 6480464 Cyclosporine results in decreased expression of CPE mRNA CTD PMID:25562108 , PMID:27989131 cylindrospermopsin decreases expression ISO RGD:732381 6480464 cylindrospermopsin results in decreased expression of CPE mRNA CTD PMID:24921660 dexamethasone increases expression ISO RGD:732382 6480464 Dexamethasone results in increased expression of CPE mRNA alternative form CTD PMID:25426952 dexamethasone multiple interactions ISO RGD:732381 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of CPE mRNA CTD PMID:28628672 dexamethasone multiple interactions EXP 6480464 Testosterone inhibits the reaction [Dexamethasone results in decreased expression of CPE mRNA] CTD PMID:20032058 dexamethasone decreases expression EXP 6480464 Dexamethasone results in decreased expression of CPE mRNA CTD PMID:20032058 dibenz[a,h]anthracene increases expression ISO RGD:732382 6480464 1 more ... CTD PMID:26377693 dibutyl phthalate increases expression ISO RGD:732382 6480464 Dibutyl Phthalate results in increased expression of CPE mRNA CTD PMID:21266533 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of CPE mRNA CTD PMID:21266533 dioxygen multiple interactions ISO RGD:732381 6480464 Oxygen deficiency inhibits the reaction [darinaparsin results in increased expression of CPE mRNA] CTD PMID:22535156 diuron decreases expression EXP 6480464 Diuron results in decreased expression of CPE mRNA CTD PMID:21551480 dorsomorphin multiple interactions ISO RGD:732381 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin increases expression ISO RGD:732381 6480464 Doxorubicin results in increased expression of CPE mRNA CTD PMID:29803840 ethanol multiple interactions ISO RGD:732382 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in increased expression of CPE mRNA CTD PMID:30517762 ethanol affects splicing ISO RGD:732382 6480464 Ethanol affects the splicing of CPE mRNA CTD PMID:30319688 ethanol affects expression ISO RGD:732382 6480464 Ethanol affects the expression of CPE mRNA CTD PMID:30319688 ethanol increases expression ISO RGD:732382 6480464 Ethanol results in increased expression of CPE mRNA CTD PMID:30319688 ethanol decreases expression ISO RGD:732381 6480464 Ethanol results in decreased expression of CPE mRNA CTD PMID:28986285 flavonoids increases expression EXP 6480464 Flavonoids results in increased expression of CPE mRNA CTD PMID:18035473 fonofos increases methylation ISO RGD:732381 6480464 Fonofos results in increased methylation of CPE promoter CTD PMID:22847954 furan decreases methylation EXP 6480464 furan results in decreased methylation of CPE gene CTD PMID:27387713 furan increases expression EXP 6480464 furan results in increased expression of CPE mRNA CTD PMID:27387713 genistein decreases expression EXP 6480464 Genistein results in decreased expression of CPE mRNA CTD PMID:12075121 hydroquinone O-beta-D-glucopyranoside increases expression ISO RGD:732381 6480464 Arbutin results in increased expression of CPE mRNA CTD PMID:17103032 indometacin multiple interactions ISO RGD:732381 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of CPE mRNA CTD PMID:28628672 irinotecan increases expression ISO RGD:732381 6480464 Irinotecan analog results in increased expression of CPE mRNA CTD PMID:18927307 kojic acid increases expression ISO RGD:732381 6480464 kojic acid results in increased expression of CPE mRNA CTD PMID:16595896 lead(0) affects expression ISO RGD:732381 6480464 Lead affects the expression of CPE mRNA CTD PMID:28903495 lead(2+) affects expression ISO RGD:732381 6480464 Lead affects the expression of CPE mRNA CTD PMID:28903495 mercaptopurine increases expression EXP 6480464 Mercaptopurine results in increased expression of CPE mRNA CTD PMID:23358152 mercury dibromide increases expression ISO RGD:732381 6480464 mercuric bromide results in increased expression of CPE mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:732381 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CPE mRNA CTD PMID:27188386 methacholine chloride increases response to substance ISO RGD:732382 6480464 CPE gene mutant form results in increased susceptibility to Methacholine Chloride CTD PMID:16002559 methylmercury chloride increases expression ISO RGD:732381 6480464 methylmercuric chloride results in increased expression of CPE mRNA CTD PMID:28001369 mifepristone decreases expression EXP 6480464 Mifepristone results in decreased expression of CPE mRNA CTD PMID:25972201 morphine increases expression ISO RGD:732382 6480464 Morphine results in increased expression of CPE mRNA CTD PMID:20144693 N-acetyl-L-cysteine decreases expression ISO RGD:732381 6480464 Acetylcysteine results in decreased expression of CPE mRNA CTD PMID:16084531 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CPE mRNA CTD PMID:18164116 nickel atom decreases expression ISO RGD:732381 6480464 Nickel results in decreased expression of CPE mRNA CTD PMID:24768652 , PMID:25583101 nickel sulfate decreases expression ISO RGD:732381 6480464 nickel sulfate results in decreased expression of CPE mRNA CTD PMID:22714537 organophosphorus compound decreases activity ISO RGD:732381 6480464 Organophosphorus Compounds results in decreased activity of CPE protein CTD PMID:17955620 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of CPE mRNA CTD PMID:25729387 oxaliplatin increases expression EXP 6480464 oxaliplatin results in increased expression of CPE mRNA CTD PMID:25729387 ozone decreases expression ISO RGD:732382 6480464 Ozone results in decreased expression of CPE mRNA CTD PMID:12763052 ozone multiple interactions ISO RGD:732382 6480464 [CPE affects the susceptibility to Ozone] which affects the expression of CSF3 protein more ... CTD PMID:16002559 , PMID:23434795 ozone affects response to substance ISO RGD:732382 6480464 CPE affects the susceptibility to Ozone CTD PMID:23434795 ozone increases response to substance ISO RGD:732382 6480464 CPE gene mutant form results in increased susceptibility to Ozone CTD PMID:16002559 panobinostat increases expression ISO RGD:732381 6480464 panobinostat results in increased expression of CPE mRNA CTD PMID:26272509 panobinostat multiple interactions ISO RGD:732381 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CPE mRNA CTD PMID:27188386 parathion increases methylation ISO RGD:732381 6480464 Parathion results in increased methylation of CPE promoter CTD PMID:22847954 phenobarbital multiple interactions ISO RGD:732382 6480464 NR1I3 protein affects the reaction [Phenobarbital results in increased expression of CPE mRNA] CTD PMID:19482888 phenobarbital increases expression ISO RGD:732382 6480464 Phenobarbital results in increased expression of CPE mRNA CTD PMID:19482888 , PMID:23091169 phenylmercury acetate increases expression ISO RGD:732381 6480464 Phenylmercuric Acetate results in increased expression of CPE mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:732381 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CPE mRNA CTD PMID:27188386 potassium chromate decreases expression ISO RGD:732381 6480464 potassium chromate(VI) results in decreased expression of CPE mRNA CTD PMID:22714537 propiconazole increases expression ISO RGD:732382 6480464 propiconazole results in increased expression of CPE mRNA CTD PMID:21278054 purine-6-thiol increases expression EXP 6480464 Mercaptopurine results in increased expression of CPE mRNA CTD PMID:23358152 raloxifene affects expression EXP 6480464 Raloxifene Hydrochloride affects the expression of CPE mRNA CTD PMID:16079270 reserpine increases expression EXP 6480464 Reserpine results in increased expression of CPE mRNA CTD PMID:8189248 SB 431542 multiple interactions ISO RGD:732381 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide decreases expression ISO RGD:732381 6480464 Silicon Dioxide analog results in decreased expression of CPE mRNA, Silicon Dioxide results in decreased expression of CPE mRNA CTD PMID:25351596 , PMID:25895662 silicon dioxide increases expression ISO RGD:732381 6480464 Silicon Dioxide analog results in increased expression of CPE mRNA CTD PMID:23806026 tamoxifen affects expression ISO RGD:732381 6480464 Tamoxifen affects the expression of CPE mRNA CTD PMID:14699072 tamoxifen affects expression ISO RGD:732382 6480464 Tamoxifen affects the expression of CPE mRNA CTD PMID:17555576 terbufos increases methylation ISO RGD:732381 6480464 terbufos results in increased methylation of CPE promoter CTD PMID:22847954 tert-butyl hydroperoxide decreases expression ISO RGD:732381 6480464 tert-Butylhydroperoxide results in decreased expression of CPE mRNA CTD PMID:12419474 tert-butyl hydroperoxide increases expression ISO RGD:732381 6480464 tert-Butylhydroperoxide results in increased expression of CPE mRNA CTD PMID:15336504 testosterone multiple interactions EXP 6480464 Testosterone inhibits the reaction [Dexamethasone results in decreased expression of CPE mRNA] CTD PMID:20032058 tetrachloromethane increases expression ISO RGD:732382 6480464 Carbon Tetrachloride results in increased expression of CPE mRNA CTD PMID:17484886 , PMID:27339419 tetrachloromethane multiple interactions ISO RGD:732382 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in increased expression of CPE mRNA CTD PMID:30517762 titanium dioxide decreases expression ISO RGD:732382 6480464 titanium dioxide results in decreased expression of CPE mRNA CTD PMID:23409001 , PMID:23557971 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of CPE mRNA CTD PMID:25729387 topotecan increases expression EXP 6480464 Topotecan results in increased expression of CPE mRNA CTD PMID:25729387 trichostatin A increases expression ISO RGD:732381 6480464 trichostatin A results in increased expression of CPE mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:732381 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CPE mRNA CTD PMID:27188386 tunicamycin increases expression ISO RGD:732381 6480464 Tunicamycin results in increased expression of CPE mRNA CTD PMID:29453283 valproic acid affects expression ISO RGD:732381 6480464 Valproic Acid affects the expression of CPE mRNA CTD PMID:25979313 valproic acid increases expression ISO RGD:732381 6480464 Valproic Acid results in increased expression of CPE mRNA CTD PMID:23179753 more ... valproic acid multiple interactions ISO RGD:732381 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CPE mRNA CTD PMID:27188386 vancomycin decreases expression ISO RGD:732382 6480464 Vancomycin results in decreased expression of CPE mRNA CTD PMID:18930951 vorinostat multiple interactions ISO RGD:732381 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CPE mRNA CTD PMID:27188386 vorinostat increases expression ISO RGD:732381 6480464 vorinostat results in increased expression of CPE mRNA CTD PMID:26272509
Biological Process cardiac left ventricle morphogenesis ISO RGD:732381 1624291 (PMID:19593212) RGD PMID:19593212 cardiac left ventricle morphogenesis IEA UniProtKB:P16870 , ensembl:ENSP000003861041600115 GO_REF:0000107 Ensembl GO_REF:0000107 enkephalin processing IDA 6483103 RGD insulin processing IDA 1626225 RGD insulin processing IEA UniProtKB:Q00493 , ensembl:ENSMUSP000000485551600115 GO_REF:0000107 Ensembl GO_REF:0000107 insulin processing ISO RGD:732382 1624291 MGI:MGI:1856395 (MGI:MGI:73445 , PMID:7663508) RGD MGI:MGI:73445 , PMID:7663508 negative regulation of branching morphogenesis of a nerve IMP 6483099 RGD peptide catabolic process IDA 1626225 RGD peptide hormone processing TAS 727682 RGD peptide hormone secretion ISO RGD:732382 1624291 MGI:MGI:1856395 (MGI:MGI:3607040 , PMID:16219686) RGD MGI:MGI:3607040 , PMID:16219686 peptide hormone secretion IEA UniProtKB:Q00493 , ensembl:ENSMUSP000000485551600115 GO_REF:0000107 Ensembl GO_REF:0000107 peptide metabolic process IDA 1626212 RGD peptide metabolic process IBA PANTHER:PTN000164240 , RGD:2394 13792537 PMID:21873635 GO_Central protein localization to membrane ISO RGD:732381 1624291 (PMID:19166515) RGD PMID:19166515 protein localization to membrane IEA UniProtKB:P16870 , ensembl:ENSP000003861041600115 GO_REF:0000107 Ensembl GO_REF:0000107 protein localization to secretory granule ISO RGD:732382 1624291 MGI:MGI:1856395 (MGI:MGI:3607040 , PMID:16219686) RGD MGI:MGI:3607040 , PMID:16219686 protein localization to secretory granule IEA UniProtKB:Q00493 , ensembl:ENSMUSP000000485551600115 GO_REF:0000107 Ensembl GO_REF:0000107 protein processing IDA 1626225 RGD protein processing IBA PANTHER:PTN000164240 more ... 13792537 PMID:21873635 GO_Central Wnt signaling pathway ISO RGD:732381 1624291 (PMID:22824791) RGD PMID:22824791 Wnt signaling pathway IEA UniProtKB:P16870 , ensembl:ENSP000003861041600115 GO_REF:0000107 Ensembl GO_REF:0000107 Cellular Component dendrite IDA 6483326 PMID:19166515 BHF-UCL dendrite IDA 2308893 RGD dense core granule IDA 6483099 RGD extracellular region IDA 6483348 RGD extracellular space IDA 1626217 RGD extracellular space IBA MGI:MGI:1934569 more ... 13792537 PMID:21873635 GO_Central extracellular space IBA MGI:MGI:1926006 more ... 13792537 PMID:21873635 GO_Central Golgi apparatus IDA 1626218 RGD Golgi apparatus IEA UniProtKB:P16870 , ensembl:ENSP000003861041600115 GO_REF:0000107 Ensembl GO_REF:0000107 Golgi apparatus ISO RGD:732381 1624291 (PMID:19166515) RGD PMID:19166515 Golgi apparatus IDA 6483326 PMID:19166515 BHF-UCL membrane raft IDA 6483330 RGD neuronal cell body IDA 2308893 RGD perikaryon IDA 6483326 PMID:19166515 BHF-UCL perikaryon IDA 2308893 RGD secretory granule IDA 1626225 RGD secretory granule membrane IDA 6483330 RGD secretory granule membrane IEA UniProtKB:Q00493 , ensembl:ENSMUSP000000485551600115 GO_REF:0000107 Ensembl GO_REF:0000107 secretory granule membrane ISO RGD:732382 1624291 (MGI:MGI:3607040, PMID:16219686) RGD MGI:MGI:3607040 , PMID:16219686 secretory granule membrane TAS 1600115 Reactome:R-NUL-9023166 Reactome Reactome:R-NUL-9023166 secretory granule membrane TAS 1600115 Reactome:R-NUL-9023186 Reactome Reactome:R-NUL-9023186 synaptic membrane IDA 6483099 RGD transport vesicle membrane IEA UniProtKB-SubCell:SL-0245 1600115 GO_REF:0000039 UniProt GO_REF:0000039 Molecular Function carboxypeptidase activity IDA 1626225 RGD carboxypeptidase activity ISO RGD:732382 1624291 MGI:MGI:1856395 (MGI:MGI:73445 , PMID:7663508) RGD MGI:MGI:73445 , PMID:7663508 cell adhesion molecule binding ISO RGD:732381 1624291 UniProtKB:Q9UHC6 (PMID:19166515) RGD PMID:19166515 cell adhesion molecule binding IEA UniProtKB:P16870 , ensembl:ENSP000003861041600115 GO_REF:0000107 Ensembl GO_REF:0000107 cobalt ion binding IMP 1626225 RGD metallocarboxypeptidase activity IEA InterPro:IPR000834 1600115 GO_REF:0000002 InterPro GO_REF:0000002 metallocarboxypeptidase activity IBA FB:FBgn0004648 more ... 13792537 PMID:21873635 GO_Central neurexin family protein binding ISO RGD:732381 1624291 UniProtKB:Q9UHC6 (PMID:19166515) RGD PMID:19166515 neurexin family protein binding IEA UniProtKB:P16870 , ensembl:ENSP000003861041600115 GO_REF:0000107 Ensembl GO_REF:0000107 protein binding IPI RGD:732004 1626212 at the periphery of secretory granules in pituitary mammotropes and pancreatic beta cells RGD protein binding ISO RGD:732382 1624291 UniProtKB:P01193 more ... RGD MGI:MGI:3607040 , PMID:16219686 protein binding IPI RGD:620106 6483099 RGD protein binding IPI RGD:3715 6483104 RGD protein binding IPI UniProtKB:P02866 1626225 RGD protein binding IPI RGD:1349318 6483328 RGD protein binding IPI RGD:1307076 6483326 RGD protein domain specific binding IDA 6483099 Nos1ap RGD zinc ion binding IEA InterPro:IPR000834 1600115 GO_REF:0000002 InterPro GO_REF:0000002
Gene-Chemical Interaction Annotations
